Bibliographic Details
| Title: |
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study. |
| Authors: |
Yadav V; Department of Neurology, Oregon Health & Science University, L226, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA., Bourdette DN, Bowen JD, Lynch SG, Mattson D, Preiningerova J, Bever CT Jr, Simon J, Goldstein A, Burrows GG, Offner H, Ferro AJ, Vandenbark AA |
| Source: |
Autoimmune diseases [Autoimmune Dis] 2012; Vol. 2012, pp. 954739. Date of Electronic Publication: 2012 Apr 05. |
| Publication Type: |
Journal Article |
| Journal Info: |
Publisher: Wiley Country of Publication: United States NLM ID: 101546750 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2090-0430 (Electronic) Linking ISSN: 20900430 NLM ISO Abbreviation: Autoimmune Dis Subsets: PubMed not MEDLINE |
| Database: |
MEDLINE Ultimate |
